The Valley Desk

NCT05039515 · Interventional trial

A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).

Overall registry status Terminated

Phase 2

Conditions Fibrodysplasia Ossificans Progressiva

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov